Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
CHA University
CHA University
CHA University
CHA University
The Institute of Molecular and Translational Medicine, Czech Republic
Boston Children's Hospital
Jewish General Hospital
M.D. Anderson Cancer Center
SOLTI Breast Cancer Research Group
University Hospital, Montpellier
SOLTI Breast Cancer Research Group
Helse Nord-Trøndelag HF
Fundacion Clinic per a la Recerca Biomédica
Fundacion Clinic per a la Recerca Biomédica
Australian & New Zealand Children's Haematology/Oncology Group
Oncology Institute of Southern Switzerland
Peking University People's Hospital